AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
The 14th Conference on Retroviruses and Opportunistic Infections (CROI): Los Angeles, February 25th-28th.(HIGHLIGHTS)
The 14th Conference on Retroviruses and Opportunistic Infections (CROI), held in Los Angeles from February 25th to the 28th, is one of the biggest HIV science conferences held each year. As in past years, the world's leading researchers presented their findings from work they have been doing to understand, prevent, and treat HIV/AIDS and its complications. Continuing our tradition at The Center for AIDS, this issue of HIV Treatment ALERTS! provides our readers with a snapshot of some very exciting studies.
New treatments are being developed to control HIV disease, especially for those who are highly treatment-experienced. Researchers are discovering that some ...
- New drug sweeps clean in HIV model. (PMPA)
- Magazine article from: Science News Centofanti, Marjorie November 18, 1995 700+ words
...AZT (zidovudine). The new drug may be most useful soon...studies of the drug on HIV infections." The simian...for PMPA in preventing HIV in health care workers...their sights on using the new drug to eliminate HIV in babies born to infected...
- New Drug Classes Drive Expanding HIV Market.
- Magazine article from: Chemical Market Reporter MIRASOL, FELIZA April 17, 2000 700+ words
...such as the new class of anri-HIV drugs known as fusion inhibitors...designation for the treatment of HIV-infected individuals. Trimeris expects to submit a new drug application by the end of 2001...category of developmental anti-HIV compounds known as entry inhibitors...
- NIAID BEGINS STUDY OF NEW DRUG FOR HIV INFECTION
- Press release article from: PR Newswire March 22, 1993 700+ words
...to evaluate a potent new anti-HIV agent, both alone and in combination with one or two other drugs, in HIV-infected persons. The new drug, U-90,152, has blocked the replication and spread of HIV in laboratory tests. "The currently...
- Investigational new drug application to be filed for HIV vaccine.
- Newspaper article from: Immunotherapy Weekly January 21, 2004 700+ words
...filing of an Investigational New Drug Application (IND) with the...clinical trial for a new DNA-based HIV vaccine, and a new strategic...between the two companies. The new HIV vaccine incorporates proprietary...School (UMMS) and ABL. The HIV Vaccine project has been funded...
- CytRx Announces Plans for Filing of Investigational New Drug Application for...
- Press release article from: PR Newswire December 23, 2003 700+ words
...filing of an Investigational New Drug Application (IND) with the...clinical trial for a new DNA-based HIV vaccine, and a new strategic...between the two companies. The new HIV vaccine incorporates proprietary...School (UMMS) and ABL. The HIV Vaccine project has been funded...
- Biosyn, Inc. Submits Investigational New Drug Application for Novel HIV...
- Press release article from: PR Newswire June 23, 2003 700+ words
...has submitted an Investigational New Drug (IND) application to the U.S...the development of UC-781 as an HIV microbicide. Biosyn plans to initiate...to prevent sexual transmission of HIV. UC-781 is an HIV non-nucleoside reverse transcriptase...
- New drug for HIV patients.(HIV update)
- Magazine article from: Medical Laboratory Observer May 1, 2007 700+ words
...patients suffering from advanced HIV who were not responding to antiretroviral...drugs along with either the new drug or a placebo. After a period...weeks, the patients using the new drug had a 98% drop in the amount of HIV material in their blood compared...
- Merck Announces FDA Acceptance of Supplemental New Drug Application for...
- Newspaper article from: AIDS Vaccine Week December 29, 2008 700+ words
...has accepted the supplemental New Drug Application (sNDA) filing for...ISENTRESS in combination with other HIV medicines for treatment in adult...previously untreated (naive) for HIV. Merck expects FDA action in...treatments for patients infected with HIV,o said Peter S. Kim, Ph...
Source: HighBeam Research, The 14th Conference on Retroviruses and Opportunistic Infections...